CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

The Lancet
Original article

[Comment] Adjuvant radiotherapy for atypical meningioma

Neutral
AI Analysis

Summary

The Lancet publishes a clinical commentary discussing the role of adjuvant radiotherapy in treating atypical meningiomas (WHO grade 2), noting that while it is well-established for residual tumors, its benefit remains controversial after gross total resection given potential toxicities.

Importance:1/10
Sentiment:
0.00
commentarymeningiomaradiotherapyoncologytreatment guidelines

Read the original article

Published by The Lancet on September 25, 2026 10:08 AM

Read Original